ADC & XDC Development, from Chemistry to Clinic

ADC & XDC Development, from Chemistry to Clinic

Antibody-drug conjugates (ADCs) and emerging XDC modalities require tight control over chemistry, conjugation, analytics and regulatory readiness from the earliest stages. Download our two-page infosheet for an overview of Ardena’s integrated capabilities, spanning linker and payload chemistry, conjugation, clinical manufacturing and GLP bioanalysis.

 

Related Resources

Our team members share deep, scientific understanding and insights into their respective fields of expertise.

Want to hear more from Ardena?

Sign up to receive drug development insights, the latest on industry trends & Ardena news.

Stay up to date with our latest news and announcements.
Get deep, scientific understanding and insights into our key fields of expertise.
See the events we're attending and register for webinars we're hosting.